Ashley W Johnston1, Steven Wolf2, Muhammad H Alkazemi3, Gina-Maria Pomann4, Hadley Wood5, John S Wiener6, Jonathan C Routh7. 1. Division of Urology, Duke University Medical Center, Durham, NC, USA. Electronic address: Ashley.wietsma@duke.edu. 2. Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA. Electronic address: Steven.Wolf@duke.edu. 3. School of Medicine, Duke University Medical Center, Durham, NC, USA. Electronic address: Muhammad.Alkazemi@duke.edu. 4. Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA. Electronic address: Gina-Maria.Pomann@duke.edu. 5. Department of Urology, Cleveland Clinic, Cleveland, OH, USA. Electronic address: WoodH@ccf.org. 6. Division of Urology, Duke University Medical Center, Durham, NC, USA. Electronic address: John.Wiener@duke.edu. 7. Division of Urology, Duke University Medical Center, Durham, NC, USA. Electronic address: jonathan.routh@duke.edu.
Abstract
BACKGROUND: Advances in medical care have increased the long-term survival of patients with spina bifida. Despite this growing population, limited knowledge is available on age-related illnesses in adults with spina bifida, particularly prostate cancer for which there is no published data. OBJECTIVE: Our aim was to describe inpatient care for prostate cancer in men with spina bifida in the United States. METHODS: We performed a descriptive, retrospective study utilizing the 1998 to 2014 National Inpatient Sample from the Healthcare Cost and Utilization Project. Weights were applied to the sample to make national level inferences. We identified all adult encounters (≥18 years old) with prostate cancer and spina bifida. RESULTS: We identified 253 encounters (mean age 64.9 years). Most were Caucasian (67.5%) and had public insurance (61.6%). 44% of encounters included a major urologic procedure. 38.4% of encounters included prostatectomies, 28.3% included lymph node dissections, and 7.8% included cystectomies. Robotic surgery was performed in 9.4%. Mean length of stay was 5.6 days (95% CI: 3.7, 7.5). The average total cost was $14,074 (95% CI: $8990.3, $19,158.6). CONCLUSIONS: In this first-ever exploration of inpatient care for prostate cancer in men with spina bifida, we found that length of stay and total costs were higher in men with spina bifida. Almost half of encounters included a prostatectomy, cystectomy, and/or lymph node dissection. More detailed investigations are necessary to assess comparative treatment outcomes and complications, including prevalence and mortality rates of prostate cancer among adult men with SB.
BACKGROUND: Advances in medical care have increased the long-term survival of patients with spina bifida. Despite this growing population, limited knowledge is available on age-related illnesses in adults with spina bifida, particularly prostate cancer for which there is no published data. OBJECTIVE: Our aim was to describe inpatient care for prostate cancer in men with spina bifida in the United States. METHODS: We performed a descriptive, retrospective study utilizing the 1998 to 2014 National Inpatient Sample from the Healthcare Cost and Utilization Project. Weights were applied to the sample to make national level inferences. We identified all adult encounters (≥18 years old) with prostate cancer and spina bifida. RESULTS: We identified 253 encounters (mean age 64.9 years). Most were Caucasian (67.5%) and had public insurance (61.6%). 44% of encounters included a major urologic procedure. 38.4% of encounters included prostatectomies, 28.3% included lymph node dissections, and 7.8% included cystectomies. Robotic surgery was performed in 9.4%. Mean length of stay was 5.6 days (95% CI: 3.7, 7.5). The average total cost was $14,074 (95% CI: $8990.3, $19,158.6). CONCLUSIONS: In this first-ever exploration of inpatient care for prostate cancer in men with spina bifida, we found that length of stay and total costs were higher in men with spina bifida. Almost half of encounters included a prostatectomy, cystectomy, and/or lymph node dissection. More detailed investigations are necessary to assess comparative treatment outcomes and complications, including prevalence and mortality rates of prostate cancer among adult men with SB.
Authors: Kirsten L Simmons; Jason C Chandrapal; Steven Wolf; Henry E Rice; Elisabeth E Tracy; Tamara Fitzgerald; Gina-Maria Pomann; Jonathan C Routh Journal: J Pediatr Urol Date: 2021-03-19 Impact factor: 1.921